Global Developmental Delay and Regression

Chapter 7 Global Developmental Delay and Regression




Developmental delay occurs in approximately 1% to 3% of children. Since developmental delay is common, monitoring a child’s development is an essential component of well-child care. Ongoing assessment of the child’s development at each well-child visit creates a pattern of development that is more useful than measuring the discrete milestone achievements at a single visit; therefore, developmental screening should be completed at each well-child visit (Council on Children with Disabilities, 2006). Identification of a child with developmental delays should be accomplished as early as possible, because the earlier a child is identified, the sooner the child can receive a thorough evaluation and begin therapeutic interventions that can improve the child’s outcome. Developmental delay is common and one of the most frequent presenting complaints to a pediatric neurology clinic; neurologists should have a systematic approach to the child with developmental delay.


This chapter begins with a brief discussion of child development concepts related to typical and atypical development. Next, the clinical evaluation and management of developmental delay is reviewed. The chapter closes with a discussion of neurological regression.



Typical and Atypical Development



Child Development Concepts


Child development is a continuous process of acquiring new and advanced skills. This development depends on maturation of the nervous system. Although typical child development follows a relatively consistent sequence, it is not linear. Instead, there are spurts and lags. For example, motor development in the first year of life proceeds relatively rapidly. Babies typically mature from being completely immobile to walking in just over 12 months, but then motor development progresses less dramatically during the second year of life. Conversely, language development in the first year of life occurs slowly, but there is an explosion of language acquisition between a child’s first and second birthdays.


On average, most children achieve each developmental milestone within a defined and narrow age range (Table 7.1). Usually physicians learn the average age for acquiring specific skills. However, since each developmental skill can be acquired within an age range, it is much more useful clinically to know when a child’s development falls outside this range. These so-called red flags are important because they can be used to identify when a child has developmental delay for specific skills. For example, although the average age of walking is approximately 13 months, a child may walk as late as 17 months and still be within the typical developmental range. In this example, the red flag for independent walking is 18 months, and a child who is not walking by 18 months of age is delayed.




Global Developmental Delay



Developmental History


Child development is classically divided into five interdependent domains or streams: gross motor, fine motor and problem-solving, receptive language, expressive language, and socialization/adaptive. The approach to a child with possible developmental delays is based on a working knowledge of these domains and the typical age ranges for acquiring specific milestones within each domain. Therefore, the clinician should begin the evaluation of a child with developmental concerns by obtaining a developmental history, and emphasis should be placed on the pattern of milestone acquisition as well as the child’s current developmental skills. Clinicians working in a busy clinical setting may need to base this history primarily on the caregiver’s report of the child’s developmental abilities. Clinicians may also use standardized tools to aid in this portion of the history, including the Ireton Child Development Inventory (CDI), the Ages and Stages Questionnaire (ASQ), and the Parents’ Evaluation of Developmental Status (PEDS). However, if the clinician’s history confirms a developmental disability, standardized testing by a developmental specialist or clinical psychologist should be strongly considered; this formal evaluation will provide a much better assessment of the child’s developmental abilities.


When there is concern about developmental delay in a child, a developmental quotient should be calculated. The developmental quotient is the ratio of the child’s developmental age over the chronological age. The developmental quotient should be calculated for each developmental stream. Typical development is a developmental quotient greater than 70%, and atypical development it is a developmental quotient less than 70%. Toddlers and young children with atypical development are at risk for lifelong developmental problems. The term global development delay is used if a child younger than 5 to 6 years of age has a developmental quotient less than 70% in two or more domains. Children with global developmental delay should receive a thorough medical evaluation to try to determine the cause of the delay and begin management for their developmental disabilities.



Neurological and Other Medical History


For children with global developmental delay, the clinician should obtain a thorough medical history, including a detailed neurological history. Pertinent aspects of the history include the presence of any other neurological condition such as epilepsy, vision or hearing impairments, ataxia or a movement disorder, sleep impairment, and behavioral problems. The clinician should also inquire about prenatal, perinatal, and postnatal factors that can impact a child’s development (Tables 7.2 and 7.3). The social history should probe for environmental factors that can affect development, including physical or other forms of abuse, neglect, psychosocial deprivation, family illness, impaired personalities in family members, sociocultural stressors, and the economic status of the family.


Table 7.2 Etiology of Developmental Delay by Time of Onset








































































Prenatal/Perinatal Examples
Congenital malformations of the CNS Lissencephaly, holoprosencephaly
Chromosomal abnormalities Down syndrome, Turner syndrome
Endogenous toxins Maternal hepatic or renal failure
Exogenous toxins from maternal use Anticonvulsants, anticoagulants, alcohol, drugs of abuse
Fetal infection Congenital infections
Prematurity and/or fetal malnutrition Periventricular leukomalacia
Perinatal trauma Intracranial hemorrhage, spinal cord injury
Perinatal asphyxia Hypoxic-ischemic encephalopathy
Postnatal Examples
Inborn errors of metabolism Aminoacidopathies, mitochondrial diseases
Abnormal storage of metabolites Lysosomal storage diseases, glycogen storage diseases
Abnormal postnatal nutrition Vitamin or calorie deficiency
Endogenous toxins Hepatic failure, kernicterus
Exogenous toxins Prescription drugs, illicit substances, heavy metals
Endocrine organ failure Hypothyroidism, Addison disease
CNS infection Meningitis, encephalitis
CNS trauma Diffuse axonal injury, intracranial hemorrhage
Neoplasia Tumor infiltration, radiation necrosis
Neurocutaneous syndromes Neurofibromatosis, tuberous sclerosis complex
Neuromuscular disorders Muscular dystrophy, myotonic dystrophy
Vascular conditions Vasculitis, ischemic stroke, sinovenous thrombosis
Other Epilepsy, mood disorders, schizophrenia

CNS, Central nervous system.


From Sherr, E.H., Shevell, M.I., 2006. Mental retardation and global developmental delay, in: Swaiman, K.F., Ashwal, S., Ferriero, D.I. (Eds.), Pediatric Neurology, Principles and Practice, fifth ed. Mosby, Philadelphia.


Table 7.3 Perinatal Risk Factors for Neurologic Injury







































Maternal/Prenatal Natal Postnatal
Age <16 years or >40 years Intrauterine hypoxia: prolapsed umbilical cord, abruptio placenta, circumvallate placenta Abnormal feeding: poor sucking, weight gain, malnutrition, vomiting
Cervical or pelvic abnormalities Midforceps delivery or breech presentation Abnormal crying
Maternal illnesses: infection, shock, diabetes, nephritis, phlebitis, proteinuria, renal hypertension, thyroid disease, drug addiction, malnutrition Poor Apgar scores: cyanosis, poor respiratory effort, bradycardia, poor reflexes, hypotonia    Abnormal exam: asymmetrical face, asymmetrical extremities, dysmorphic features, hypotonia, birth injuries, seizures
Maternal features: unmarried, uneducated, nonwhite, low-income, thin, short Need for resuscitation: respiratory distress, bradycardia, hypotension Abnormal findings: hyperbilirubinemia, fever, hypothermia, hypoxia
Consanguinity Gestational age <30 weeks  
Prior abnormal pregnancy, miscarriages, stillbirths, abortions, neonatal deaths, infants less than 1500 g, abnormal placenta Vaginal bleeding in the second or third trimester  
  Hypoxic-ischemic encephalopathy  
  Polyhydramnios or oligohydramnios  

From Sherr, E.H., Shevell, M.I., 2006. Mental retardation and global developmental delay, in: Swaiman, K.F., Ashwal, S., Ferriero, D.I. (Eds.), Pediatric Neurology, Principles and Practice, fifth ed. Mosby, Philadelphia.


Though families now typically have fewer children, and the caregivers’ knowledge of family history is frequently quite limited, the clinician should still make an effort to obtain a three-generation pedigree. The pertinent aspects of the family history include developmental disabilities, special education services or failure to graduate from school, neurodegenerative disorders, multiple miscarriages or early postnatal death, ethnicity, and consanguinity. If a specific genetic syndrome is suspected, the clinician should inquire about the presence in other family members of medical problems associated with that syndrome. For example, if the child has the features of fragile X syndrome, the family history should include questions about maternal premature ovarian failure, parkinsonism or ataxia of unknown etiology in the maternal grandfather, and intellectual disability or learning problems in an X-linked pattern.



Physical Examination


The growth parameters of the child should be measured, and the growth charts should be reviewed to determine the child’s rate of growth. This is pertinent because many chromosomal anomalies and other genetic disorders that cause global developmental delay and intellectual disability are associated with failure to thrive or short stature, large stature, microcephaly, and macrocephaly.


In the mental status portion of the examination, the clinician should note the interactions the child has with his or her caregivers and the clinician. Abnormal behaviors such as impaired eye contact, limited or absent social reciprocity, restricted or repetitive behaviors, and communication impairment may indicate that the child has an autism spectrum disorder, and the child should be referred to a psychologist for assessment or confirmation of this condition. Other abnormal behaviors such as hyperactivity, impulsivity, and inattention, as well as suboptimal parenting skills, may also be noted during these observations. However, the clinician should use caution when raising concerns about a behavior problem based solely on the child’s behavior in clinic, since this stressful situation may lead the child to manifest uncharacteristic behaviors.


A complete general physical and neurological examination should be performed to the extent the child will allow. The general examination should include but not be limited to an evaluation for dysmorphic features; abnormalities of the eyes (Table 7.4), skin, and hair; and organomegaly (Table 7.5). The neurological examination should include signs of impairment in extraocular movements; hypertonia or hypotonia; focal or generalized weakness; abnormal posture or movements; abnormal or asymmetrical tendon reflexes; ataxia, incoordination or other signs of cerebellar dysfunction; and gait abnormalities (see Table 7.5).


Table 7.4 Ocular Findings Associated with Selected Syndromic Developmental Disorders







































Finding Examples
Cataracts Cerebrotendinous xanthomatosis, galactosemia, Lowe syndrome, LSD, Wilson disease
Chorioretinitis Congenital infections
Corneal opacity Cockayne syndrome, Lowe syndrome, LSD, xeroderma pigmentosa, Zellweger syndrome
Glaucoma Lowe syndrome, mucopolysaccharidoses, Sturge-Weber syndrome, Zellweger syndrome
Lens dislocation Homocystinuria, sulfite oxidase deficiency
Macular cherry-red spot LSD, multiple sulfatase deficiency
Nystagmus Aminoacidopathies, AT, CDG, Chédiak-Higashi syndrome, Friedreich ataxia, Leigh syndrome, Marinesco-Sjögren syndrome, metachromatic leukodystrophy, neuroaxonal dystrophy, Pelizaeus-Merzbacher disease, SCD
Ophthalmoplegia AT, Bassen-Kornzweig syndrome, LSDs, mitochondrial diseases   
Optic atrophy Alpers disease, Leber optic atrophy, leukodystrophies, LSDs, neuroaxonal dystrophy, SCD  
Photophobia Cockayne syndrome, Hartnup disease, homocystinuria
Retinitis pigmentosa or macular degeneration AT, Bassen-Kornzweig syndrome, Cockayne syndrome, CDG, Hallervorden-Spatz syndrome, Laurence-Moon-Biedl syndrome, LSD, mitochondrial diseases, Refsum disease, Sjögren-Larsson syndrome, SCD

AT, Ataxia-telangiectasia; CDG, congenital disorders of glycosylation; LSD, lysosomal storage diseases; SCD, spinocerebellar degeneration.


From Sherr, E.H., Shevell, M.I., 2006. Mental retardation and global developmental delay, in: Swaiman, K.F., Ashwal, S., Ferriero, D.I. (Eds.), Pediatric Neurology, Principles and Practice, fifth ed. Mosby, Philadelphia.


Table 7.5 Other Findings Associated with Selected Syndromic Developmental Disorders












































































































Finding Examples
Cerebellar dysfunction Aminoacidopathies, AT, Bassen-Kornzweig syndrome, CDG, cerebrotendinous xanthomatosis, Chédiak-Higashi syndrome, Cockayne syndrome, Friedreich ataxia, Lafora disease, LSD, Marinesco-Sjögren syndrome, mitochondrial disease, neuroaxonal dystrophy, Pelizaeus-Merzbacher disease, Ramsay Hunt syndrome, SCD, Wilson disease
Hair abnormalities:  
Synophrys Cornelia de Lange syndrome
Fine hair Homocystinuria, hypothyroidism
Kinky hair Argininosuccinic aciduria, Menkes disease
Hirsutism LSD
Balding Leigh syndrome, progeria
Gray hair AT, Chédiak-Higashi syndrome, Cockayne syndrome, progeria
Hearing abnormalities:  
Hyperacusis LSD, SSPE, sulfite oxidase deficiency
Conductive loss Mucopolysaccharidoses
Sensorineural loss Adrenoleukodystrophy, CHARGE, Cockayne syndrome, mitochondrial diseases, SCD, Refsum disease
Infantile hypotonia Canavan disease, myopathies, LSD, Leigh syndrome, Menkes disease, neuroaxonal dystrophy, spinal muscular atrophy, Zellweger disease
Limb abnormalities:  
Micromelia Cornelia de Lange syndrome
Broad thumbs Rubinstein-Taybi syndrome
Macrocephaly Alexander disease, Canavan histiocytosis X, LSD
Microcephaly Alpers disease, CDG, Cockayne syndrome, incontinentia, pigmenti, neuronal ceroid lipofuscinoses, Crabbe disease, neuroaxonal dystrophy, Rett syndrome
Movement disorders AT, LSD, dystonia musculorum deformans, Hallervorden-Spatz, juvenile Huntington disease, juvenile Parkinson disease, Lesch-Nyhan disease, phenylketonuria, Wilson disease, xeroderma pigmentosa
Odors:  
Cat urine β-Methyl-crotonyl-CoA carboxylase deficiency  
Maple Maple syrup urine disease
Musty Phenylketonuria
Rancid butter Methionine malabsorption syndrome
Sweaty feet Isovaleric acidemia
Organomegaly Aminoacidopathies, CDG, galactosemia, glycogen storage diseases, LSD, Zellweger syndrome
Peripheral neuropathy AT, Bassen-Kornzweig syndrome, cerebrotendinous xanthomatosis, Cockayne syndrome, LSD, Refsum disease
Short stature Cockayne syndrome, Cornelia de Lange syndrome, hypothyroidism, leprechaunism, LSD, Prader-Willi syndrome, Rubinstein-Taybi syndrome, Seckel bird-headed dwarfism
Seizures Aminoacidopathies, CDG, glycogen synthetase deficiency, HIE, LSD, Menkes disease, mitochondrial diseases, neuroaxonal dystrophy
Skin abnormalities:  
Hyperpigmentation
Hypopigmentation
Adrenoleukodystrophy, AT, Farber disease, neurofibromatosis, Niemann-Pick disease, tuberous sclerosis complex, xeroderma pigmentosa
Nodules Chédiak-Higashi syndrome, incontinentia pigmenti, Menkes disease, tuberous sclerosis complex
Thick skin Cerebrotendinous xanthomatosis, Farber disease, neurofibromatosis, LSD, Refsum disease,
Thin skin Sjögren-Larsson syndrome, AT, Cockayne syndrome, progeria, xeroderma pigmentosa

AT, Ataxia-telangiectasia; CDG, congenital disorders of glycosylation; CHARGE, coloboma, heart disease, choanal atresia, retardation, genital anomalies, ear anomalies; HIE, hypoxic-ischemic encephalopathy; LSD, lysosomal storage diseases; SCD, spinocerebellar degeneration; SSPE, subacute sclerosing panencephalitis.


From Sherr, E.H., Shevell, M.I., 2006. Mental retardation and global developmental delay, in: Swaiman, K.F., Ashwal, S., Ferriero, D.I. (Eds.), Pediatric Neurology, Principles and Practice, fifth ed. Mosby, Philadelphia.

< div class='tao-gold-member'>

Stay updated, free articles. Join our Telegram channel

Jun 19, 2016 | Posted by in NEUROLOGY | Comments Off on Global Developmental Delay and Regression

Full access? Get Clinical Tree

Get Clinical Tree app for offline access